SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t

por Lingor, Paul, Demleitner, Antonia F., Wolff, Andreas W., Feneberg, Emily
Publicado 2022

Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease from the Perspective of Treating Physicians—A Nationwide Cross-Sectional Study

por Wolff, Andreas Wolfgang, Haller, Bernhard, Demleitner, Antonia Franziska, Westenberg, Erica, Lingor, Paul
Publicado 2022

Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan

por Ikenberg, Benno, Demleitner, Antonia Franziska, Thiele, Thomas, Wiestler, Benedikt, Götze, Katharina, Mößmer, Georg, Lingor, Paul
Publicado 2021

Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives

por Wolff, Andreas Wolfgang, Haller, Bernhard, Demleitner, Antonia Franziska, Pürner, Dominik, Niederschweiberer, Johanna, Cordts, Isabell, Westenberg, Erica, Lingor, Paul
Publicado 2023

Parkinson’s disease therapy: what lies ahead?

por Wolff, Andreas, Schumacher, Nicolas U., Pürner, Dominik, Machetanz, Gerrit, Demleitner, Antonia F., Feneberg, Emily, Hagemeier, Maike, Lingor, Paul
Publicado 2023

Pumilio2-deficient mice show a predisposition for epilepsy

por Follwaczny, Philipp, Schieweck, Rico, Riedemann, Therese, Demleitner, Antonia, Straub, Tobias, Klemm, Anna H., Bilban, Martin, Sutor, Bernd, Popper, Bastian, Kiebler, Michael A.
Publicado 2017

Best practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic

por Demleitner, Antonia F., Wolff, Andreas W., Erber, Johanna, Gebhardt, Friedemann, Westenberg, Erica, Winkler, Andrea S., Kolbe-Busch, Susanne, Chaberny, Iris F., Lingor, Paul
Publicado 2022